Rifca Le Dieu

Dr Rifca Le Dieu is a Clinical Reader at Barts Cancer Institute, Queen Mary University of London, serving as Group Leader within the Centre for Haemato-Oncology. She holds key academic roles including Module Lead for undergraduate Biomedical Science modules (Tissue Biology for Year 1; Cellular Pathology and Blood Science for Year 3; Molecular Basis of Personalised Medicine elective) and Cancer Theme Lead for MBBS Year 2 Cancer Week, with direct responsibility for curriculum design and delivery.

Her research focuses on translational haematological oncology, specializing in Leukaemia therapeutics through Immunotherapy and Clinical Trials frameworks. She integrates Personalised Medicine approaches to optimize blood cancer treatment protocols, with emphasis on Hodgkin's Lymphoma subgroup analysis and molecular diagnostics within the Centre for Haemato-Oncology.

Professional distinctions include:

• Fellow of the Higher Education Academy
• Fellow of the Royal College of Physicians (FRCP)

She actively shapes medical workforce policy as Joint Deputy Director of the Royal College of Physicians’ Medical Workforce Unit and advocates for workplace flexibility as Barts Health NHS Trust Champion. Her clinical leadership extends to membership in the Hodgkins Lymphoma NCRI Clinical Trials Subgroup, driving national trial protocols.

As Group Leader, she directs a multidisciplinary research team focused on haematological malignancy biomarkers and therapeutic resistance mechanisms, bridging laboratory discoveries with clinical applications in blood cancer treatment.